Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 5/20 | 1.00 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.51 |
| ▸ | USP7 | Q93009 | 5/20 | 0.50 |
| ▸ | FYN | P06241 | 5/20 | 0.47 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.45 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.44 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.42 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.42 |
| ▸ | MAP4K3 | Q8IVH8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487830 | 1.00 | MET (1.00) | METMAP4K4USP7FYNTGFBR1 | |
| SCHEMBL487969 | 0.92 | MET (0.84) | METMAP4K4USP7FYNTGFBR1 | |
| SCHEMBL30453384 | 0.92 | MET (0.84) | METMAP4K4USP7FYNTGFBR1 | |
| SCHEMBL487777 | 0.91 | MET (0.83) | METMAP4K4USP7FYNMPO | |
| SCHEMBL27650091 | 0.90 | MET (0.82) | METMAP4K4USP7FYNTGFBR1 | |
| SCHEMBL487907 | 0.89 | MET (0.81) | METMAP4K4USP7FYNMPO | |
| SCHEMBL487935 | 0.89 | MET (0.80) | METMAP4K4USP7FYNMPO | |
| SCHEMBL30454836 | 0.89 | MET (0.80) | METMAP4K4USP7FYNMPO | |
| SCHEMBL30454723 | 0.88 | MET (0.79) | METMAP4K4USP7FYNTGFBR1 | |
| SCHEMBL487730 | 0.88 | MET (0.79) | METMAP4K4USP7FYNTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |